ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1253

Lipid Screening and Treatment Patterns Among Patients with Rheumatic Diseases

Alexander Peck1, Gilbert Ortega2, Jawad Bilal3, Ella Starobinska2, Phan Saligrama2 and Dominick Sudano4, 1Division of Internal Medicine, University of Arizona College of Medicine, Tucson, AZ, 2Internal Medicine, University of Arizona, Tucson, Tucson, AZ, 3Internal Medicine, University of Arizona, Tucson, AZ, 4University of Arizona Arthritis Center, University of Arizona, Tucson, AZ

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Cholesterol, lipids and rheumatic disease

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, October 22, 2018

Session Title: Measures and Measurement of Healthcare Quality Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

The importance of lipid management is well recognized in rheumatic diseases. In fact, annual cardiovascular risk assessment is especially recommended for individuals with rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. The comorbid traditional cardiovascular risk factors compound the morbidity and mortality risk. Despite an abundance of data supporting that patients with rheumatic diseases have increased rates of major adverse cardiovascular events, patients are inadequately screened and often under treated.

Methods:

We conducted a retrospective study between 2013 and 2017 at the two infusion centers affiliated with the University of Arizona Arthritis Center, and identified the patients on biological infusions with comorbid cardiovascular disease, diabetes, hyperlipidemia, hypertension or smoking, and then examined whether these patients had lipid testing done and/or were on statins during this period.

Results:

Of the total 253 patients with rheumatologic diagnoses, the mean age was 62 years and 77.5% of the sample was female. 62.5% had rheumatoid arthritis, 8.7% had osteoporosis, 5.5% had systemic lupus erythematosus, 5.1% had psoriatic arthritis, 4.7% had ankylosing spondylitis, 2.8% had mixed connective tissue disease, 2.0% had juvenile idiopathic arthritis, 2.4% had anti-neutrophil cytoplasmic antibodies vasculitis, 1.6% had osteoarthritis, 0.8% had Bechet’s disease, 0.8% had dermatomyositis, 0.8% had polymyositis, 0.8% had adult-onset still’s disease, 0.4% had giant cell arteritis, 0.4% had inclusion body myositis, 0.4% had fibromyalgia, and 0.4% had gout.

Of those with a rheumatologic diagnosis and at least one qualifying co-morbid condition, 38.72% had hypertension, 30.83% had hyperlipidemia, 18.04% had diabetes, 15% were smokers, and 6.39% of patients had known cardiovascular disease. The lipid testing was performed in 40.23% of patients, and only 29.41% were on statin therapy.

Conclusion:

The findings of this study suggested that the majority of patients (60%) with rheumatic diseases lacked lipid testing, and subsequently, cardiovascular risk stratification. Given the increased cardiovascular morbidity and mortality in these patients, rheumatologists, in collaboration with primary care physicians, can ameliorate this clinical gap by ensuring that patients receive age- and disease-appropriate risk assessments. Such screening efforts may improve treatment responses and reduce the risk of adverse cardiovascular events.


Disclosure: A. Peck, None; G. Ortega, None; J. Bilal, None; E. Starobinska, None; P. Saligrama, None; D. Sudano, None.

To cite this abstract in AMA style:

Peck A, Ortega G, Bilal J, Starobinska E, Saligrama P, Sudano D. Lipid Screening and Treatment Patterns Among Patients with Rheumatic Diseases [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/lipid-screening-and-treatment-patterns-among-patients-with-rheumatic-diseases/. Accessed February 3, 2023.
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/lipid-screening-and-treatment-patterns-among-patients-with-rheumatic-diseases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences